By Jason K. Molitoris, MD, PhD, Anthony D. Nehlsen, MD, and Minesh P. Mehta, MD Posted: October 2017 Up to 40% of patients with advanced non-small cell lung cancer (NSCLC) […] Read more
Posted: October 2017 Jean-Charles Soria, MD, PhD, has been appointed Senior Vice President, Head of Oncology Innovative Medicines at MedImmune, AstraZeneca. He will oversee research, translational sciences and early drug […] Read more
By Keightley Amen, BA, ELS Posted: October 2017 This November, survivors around the world will celebrate the second annual Lung Cancer Awareness Month (LCAM) Consortium. Together, they will celebrate a […] Read more
Posted: October 2017 Deric Savior, MD, has been appointed Head of Medical Oncology, Fox Chase Cancer Center at Temple University Hospital (TUH). Prior to this appointment, Dr. Savior led the […] Read more
By Erik J. MacLaren, PhD Posted: October 2017 Scott Gottlieb, MD, Commissioner of the U.S. Food and Drug Administration, said in a recent speech, “There’s probably no single intervention or […] Read more
What is the current standard of care in the adjuvant setting post-resection of high-risk NSCLC in your practice or nationally?Posted: October 2017 Current Chinese Lung Cancer Diagnosis and Treatment Guideline […] Read more
By Cynthia L. Kryder, MS, CCC-Sp Posted: October 2017 For patients who present with inoperable, locally advanced lung cancer, photon-based chemoradiation remains the standard of care. Despite advanced radiation-delivery techniques, […] Read more
By Cynthia L. Kryder, MS, CCC-Sp Posted: October 2017 Editor Note: The article is part of a newly launched ongoing series about immunooncology (IO) combination therapy, future articles of which […] Read more
By Carol Brimacombe, State Registered Occupational Therapist (SROT) Posted: October 2017 The emerging role of allied health professionals in the multidisciplinary thoracic cancer team (MDT) is only just being acknowledged […] Read more
By Erik J. MacLaren, PhD Posted: October 2017 On July 28, 2017, the U.S. Food and Drug Administration (FDA) announced a new, multi-year strategy intended to reduce tobacco-related disease and […] Read more